Sensitive spectrophotometric determination of lansoprazole in pharmaceuticals using ceric ammonium sulphate based on redox and complex formation reactions
Main Article Content
Abstract
Two simple sensitive and cost-effective spectrophotometric methods are described for
the determination of lansoprazole (LPZ) in bulk drug and in capsules using ceric ammonium
sulphate (CAS), iron (II), orthophenanthroline and thiocyanate as reagents. In both methods, an
acidic solution of lansoprazole is treated with a measured excess of CAS followed by the
determination of unreacted oxidant by two procedures involving different reaction schemes. The
first method involves the reduction of residual oxidant by a known amount of iron(II), and the
unreacted iron(II) is complexed with orthophenanthroline at a raised pH, and the absorbance of the
resulting complex measured at 510 nm (method A). In the second method, the unreacted CAS is
reduced by excess of iron (II), and the resulting iron (III) is complexed with thiocyanate in the acid
medium and the absorbance of the complex measured at 470 nm (method B). In both methods, the
amount CAS reacted corresponds to the amount of LPZ. In method A, the absorbance is found to
increase linearly with the concentration of LPZ where as in method B a linear decrease in
absorbance occurs.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
The corresponding author transfers the copyright of the submitted manuscript and all its versions to Eclet. Quim., after having the consent of all authors, which ceases if the manuscript is rejected or withdrawn during the review process.
When a published manuscript in EQJ is also published in other journal, it will be immediately withdrawn from EQ and the authors informed of the Editor decision.
Self-archive to institutional, thematic repositories or personal webpage is permitted just after publication. The articles published by Eclet. Quim. are licensed under the Creative Commons Attribution 4.0 International License.
References
Current Index of Medical Specialities(CIMS),
CMPMedica India Pvt Ltd., Bangalore, India, 2005, July-
October, pp. 72.
M.C. Satia, I.A. Modi, R.I. Modi, B.K. Chakravarthy &
T.P.Gandhi, J. Chromatogr.B: Biomed.Sci.Appl. 693 (1997)
J. Gan, T.W. Harper, M.M. Hsuch, Q. Qu & W.G.
Humphreys, Chem.Res.Toxicol. 18 (2005) 896.
N. Badwe, G.C. Kandapal & S.T. Hathiari, East.Pharm.
(1996) 127.
D.G. Sankar, K.D. Priya, M.V. Krishna & P.V.M. Latha,
Int.J.Chem. Sci. 3 (2005) 247.
D.Yeniceli, D. Dogaukol-Ak & M. Tuncel,
J.Pharm.Biomed. Anal. 36 (2004) 145.
A. Ramesh, K.E. Kumar, M. Sudhakar & B.K. Murthy ,
Int. J.Chem. Sci. 2 (2004) 642.
Text on Validation of Analytical Procedures”, International
conference On Harmonization of Technical Registration of
Pharmaceuticals for Human use, ICH steering committee,